Chemicals - Specialty
Compare Stocks
5 / 10Stock Comparison
ALTO vs ADM vs BG vs REX vs INGR
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural Farm Products
Agricultural Farm Products
Chemicals - Specialty
Packaged Foods
ALTO vs ADM vs BG vs REX vs INGR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Chemicals - Specialty | Agricultural Farm Products | Agricultural Farm Products | Chemicals - Specialty | Packaged Foods |
| Market Cap | $351M | $37.36B | $24.02B | $1.60B | $6.77B |
| Revenue (TTM) | $918M | $80.61B | $80.54B | $651M | $7.22B |
| Net Income (TTM) | $13M | $1.08B | $686M | $50M | $729M |
| Gross Margin | 3.8% | 5.8% | 5.2% | 12.7% | 25.3% |
| Operating Margin | 0.8% | 1.5% | 2.4% | 8.6% | 14.1% |
| Forward P/E | 15.4x | 18.6x | 14.4x | 62.8x | 9.6x |
| Total Debt | $98M | $8.41B | $16.95B | $21M | $1.79B |
| Cash & Equiv. | $26M | $1.01B | $1.14B | $196M | $1.03B |
ALTO vs ADM vs BG vs REX vs INGR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Alto Ingredients, I… (ALTO) | 100 | 680.7 | +580.7% |
| Archer-Daniels-Midl… (ADM) | 100 | 197.2 | +97.2% |
| Bunge Global S.A. (BG) | 100 | 317.3 | +217.3% |
| REX American Resour… (REX) | 100 | 498.3 | +398.3% |
| Ingredion Incorpora… (INGR) | 100 | 127.5 | +27.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ALTO vs ADM vs BG vs REX vs INGR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ALTO is the #2 pick in this set and the best alternative if momentum is your priority.
- +427.8% vs INGR's -18.4%
ADM ranks third and is worth considering specifically for income & stability and sleep-well-at-night.
- Dividend streak 31 yrs, beta 0.12, yield 2.6%
- Lower volatility, beta 0.12, Low D/E 36.5%, current ratio 11.20x
- Beta 0.12, yield 2.6%, current ratio 11.20x
- Beta 0.12 vs REX's 0.36
BG is the clearest fit if your priority is growth exposure.
- Rev growth 32.4%, EPS growth -38.4%, 3Y rev CAGR 1.5%
- 32.4% revenue growth vs REX's -22.9%
REX is the clearest fit if your priority is long-term compounding.
- 464.7% 10Y total return vs ADM's 147.4%
INGR carries the broadest edge in this set and is the clearest fit for valuation efficiency.
- PEG 0.57 vs REX's 1.18
- Lower P/E (9.6x vs 62.8x), PEG 0.57 vs 1.18
- 10.1% margin vs BG's 0.9%
- 3.0% yield, 3-year raise streak, vs ADM's 2.6%, (1 stock pays no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 32.4% revenue growth vs REX's -22.9% | |
| Value | Lower P/E (9.6x vs 62.8x), PEG 0.57 vs 1.18 | |
| Quality / Margins | 10.1% margin vs BG's 0.9% | |
| Stability / Safety | Beta 0.12 vs REX's 0.36 | |
| Dividends | 3.0% yield, 3-year raise streak, vs ADM's 2.6%, (1 stock pays no dividend) | |
| Momentum (1Y) | +427.8% vs INGR's -18.4% | |
| Efficiency (ROA) | 9.4% ROA vs BG's 1.6%, ROIC 15.5% vs 3.3% |
ALTO vs ADM vs BG vs REX vs INGR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ALTO vs ADM vs BG vs REX vs INGR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
INGR leads in 3 of 6 categories
REX leads 1 • ADM leads 1 • ALTO leads 0 • BG leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
INGR leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ADM is the larger business by revenue, generating $80.6B annually — 123.9x REX's $651M. INGR is the more profitable business, keeping 10.1% of every revenue dollar as net income compared to BG's 0.9%. On growth, BG holds the edge at +87.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $918M | $80.6B | $80.5B | $651M | $7.2B |
| EBITDAEarnings before interest/tax | $33M | $3.0B | $2.8B | $67M | $1.2B |
| Net IncomeAfter-tax profit | $13M | $1.1B | $686M | $50M | $729M |
| Free Cash FlowCash after capex | $9M | $4.8B | $112M | $18M | $809M |
| Gross MarginGross profit ÷ Revenue | +3.8% | +5.8% | +5.2% | +12.7% | +25.3% |
| Operating MarginEBIT ÷ Revenue | +0.8% | +1.5% | +2.4% | +8.6% | +14.1% |
| Net MarginNet income ÷ Revenue | +1.5% | +1.3% | +0.9% | +7.7% | +10.1% |
| FCF MarginFCF ÷ Revenue | +0.9% | +6.0% | +0.1% | +2.7% | +11.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -1.9% | +1.6% | +87.8% | +0.4% | -2.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +149.1% | +1.6% | -76.4% | +2.9% | +79.0% |
Valuation Metrics
INGR leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 9.6x trailing earnings, INGR trades at a 72% valuation discount to ADM's 34.8x P/E. Adjusting for growth (PEG ratio), REX offers better value at 0.55x vs INGR's 0.57x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $351M | $37.4B | $24.0B | $1.6B | $6.8B |
| Enterprise ValueMkt cap + debt − cash | $423M | $44.8B | $39.8B | $1.4B | $7.5B |
| Trailing P/EPrice ÷ TTM EPS | 28.38x | 34.77x | 25.16x | 29.50x | 9.61x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.39x | 18.63x | 14.38x | 62.81x | 9.56x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.55x | 0.57x |
| EV / EBITDAEnterprise value multiple | 12.84x | 17.18x | 22.60x | 16.60x | 5.98x |
| Price / SalesMarket cap ÷ Revenue | 0.38x | 0.47x | 0.34x | 2.50x | 0.94x |
| Price / BookPrice ÷ Book value/share | 1.40x | 1.63x | 1.18x | 2.67x | 1.60x |
| Price / FCFMarket cap ÷ FCF | 40.58x | 8.89x | — | — | 13.25x |
Profitability & Efficiency
INGR leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
INGR delivers a 17.1% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $4 for BG. REX carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to BG's 0.97x. On the Piotroski fundamental quality scale (0–9), INGR scores 8/9 vs BG's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +6.0% | +4.7% | +4.3% | +7.7% | +17.1% |
| ROA (TTM)Return on assets | +3.4% | +2.2% | +1.6% | +6.7% | +9.4% |
| ROICReturn on invested capital | +1.9% | +3.3% | +3.3% | +11.4% | +15.5% |
| ROCEReturn on capital employed | +2.3% | +4.2% | +4.5% | +10.1% | +16.3% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 2 | 5 | 8 |
| Debt / EquityFinancial leverage | 0.40x | 0.37x | 0.97x | 0.03x | 0.41x |
| Net DebtTotal debt minus cash | $72M | $7.4B | $15.8B | -$175M | $760M |
| Cash & Equiv.Liquid assets | $26M | $1.0B | $1.1B | $196M | $1.0B |
| Total DebtShort + long-term debt | $98M | $8.4B | $17.0B | $21M | $1.8B |
| Interest CoverageEBIT ÷ Interest expense | -0.93x | 3.03x | 3.10x | — | 27.32x |
Total Returns (Dividends Reinvested)
REX leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in REX five years ago would be worth $34,996 today (with dividends reinvested), compared to $7,882 for ALTO. Over the past 12 months, ALTO leads with a +427.8% total return vs INGR's -18.4%. The 3-year compound annual growth rate (CAGR) favors REX at 50.8% vs INGR's 2.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +70.7% | +32.2% | +34.4% | +50.2% | -0.7% |
| 1-Year ReturnPast 12 months | +427.8% | +66.2% | +66.8% | +147.6% | -18.4% |
| 3-Year ReturnCumulative with dividends | +233.8% | +10.7% | +46.3% | +243.1% | +7.9% |
| 5-Year ReturnCumulative with dividends | -21.2% | +29.2% | +49.4% | +250.0% | +28.8% |
| 10-Year ReturnCumulative with dividends | +6.8% | +147.4% | +140.3% | +464.7% | +13.5% |
| CAGR (3Y)Annualised 3-year return | +49.5% | +3.4% | +13.5% | +50.8% | +2.6% |
Risk & Volatility
ADM leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ADM is the less volatile stock with a 0.12 beta — it tends to amplify market swings less than REX's 0.36 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ADM currently trades 94.8% from its 52-week high vs INGR's 75.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.30x | 0.12x | 0.25x | 0.36x | 0.25x |
| 52-Week HighHighest price in past year | $5.99 | $81.75 | $133.93 | $53.36 | $141.78 |
| 52-Week LowLowest price in past year | $0.80 | $46.81 | $71.60 | $19.44 | $100.71 |
| % of 52W HighCurrent price vs 52-week peak | +75.8% | +94.8% | +92.4% | +91.2% | +75.8% |
| RSI (14)Momentum oscillator 0–100 | 61.1 | 68.4 | 51.8 | 59.1 | 27.3 |
| Avg Volume (50D)Average daily shares traded | 2.1M | 3.8M | 1.7M | 204K | 585K |
Analyst Outlook
Evenly matched — ADM and INGR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ALTO as "Buy", ADM as "Hold", BG as "Buy", REX as "Buy", INGR as "Hold". Consensus price targets imply 23.3% upside for REX (target: $60) vs -22.9% for ALTO (target: $4). For income investors, INGR offers the higher dividend yield at 3.01% vs ALTO's 0.37%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $3.50 | $60.00 | $133.67 | $60.00 | $124.25 |
| # AnalystsCovering analysts | 2 | 36 | 25 | 3 | 21 |
| Dividend YieldAnnual dividend ÷ price | +0.4% | +2.6% | +2.2% | — | +3.0% |
| Dividend StreakConsecutive years of raises | 0 | 31 | 5 | — | 3 |
| Dividend / ShareAnnual DPS | $0.02 | $2.04 | $2.76 | — | $3.24 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +2.3% | +0.9% | +3.3% |
INGR leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). REX leads in 1 (Total Returns). 1 tied.
ALTO vs ADM vs BG vs REX vs INGR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ALTO or ADM or BG or REX or INGR a better buy right now?
For growth investors, Bunge Global S.
A. (BG) is the stronger pick with 32. 4% revenue growth year-over-year, versus -22. 9% for REX American Resources Corporation (REX). Ingredion Incorporated (INGR) offers the better valuation at 9. 6x trailing P/E (9. 6x forward), making it the more compelling value choice. Analysts rate Alto Ingredients, Inc. (ALTO) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ALTO or ADM or BG or REX or INGR?
On trailing P/E, Ingredion Incorporated (INGR) is the cheapest at 9.
6x versus Archer-Daniels-Midland Company at 34. 8x. On forward P/E, Ingredion Incorporated is actually cheaper at 9. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Ingredion Incorporated wins at 0. 57x versus REX American Resources Corporation's 1. 18x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ALTO or ADM or BG or REX or INGR?
Over the past 5 years, REX American Resources Corporation (REX) delivered a total return of +250.
0%, compared to -21. 2% for Alto Ingredients, Inc. (ALTO). Over 10 years, the gap is even starker: REX returned +464. 7% versus ALTO's +6. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ALTO or ADM or BG or REX or INGR?
By beta (market sensitivity over 5 years), Archer-Daniels-Midland Company (ADM) is the lower-risk stock at 0.
12β versus REX American Resources Corporation's 0. 36β — meaning REX is approximately 216% more volatile than ADM relative to the S&P 500. On balance sheet safety, REX American Resources Corporation (REX) carries a lower debt/equity ratio of 3% versus 97% for Bunge Global S. A. — giving it more financial flexibility in a downturn.
05Which is growing faster — ALTO or ADM or BG or REX or INGR?
By revenue growth (latest reported year), Bunge Global S.
A. (BG) is pulling ahead at 32. 4% versus -22. 9% for REX American Resources Corporation (REX). On earnings-per-share growth, the picture is similar: Alto Ingredients, Inc. grew EPS 119. 5% year-over-year, compared to -38. 9% for Archer-Daniels-Midland Company. Over a 3-year CAGR, BG leads at 1. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ALTO or ADM or BG or REX or INGR?
Ingredion Incorporated (INGR) is the more profitable company, earning 10.
1% net margin versus 1. 2% for Bunge Global S. A. — meaning it keeps 10. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: INGR leads at 14. 4% versus 0. 8% for ALTO. At the gross margin level — before operating expenses — INGR leads at 25. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ALTO or ADM or BG or REX or INGR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Ingredion Incorporated (INGR) is the more undervalued stock at a PEG of 0. 57x versus REX American Resources Corporation's 1. 18x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Ingredion Incorporated (INGR) trades at 9. 6x forward P/E versus 62. 8x for REX American Resources Corporation — 53. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for REX: 23. 3% to $60. 00.
08Which pays a better dividend — ALTO or ADM or BG or REX or INGR?
In this comparison, INGR (3.
0% yield), ADM (2. 6% yield), BG (2. 2% yield), ALTO (0. 4% yield) pay a dividend. REX does not pay a meaningful dividend and should not be held primarily for income.
09Is ALTO or ADM or BG or REX or INGR better for a retirement portfolio?
For long-horizon retirement investors, Archer-Daniels-Midland Company (ADM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
12), 2. 6% yield, +147. 4% 10Y return). Both have compounded well over 10 years (ADM: +147. 4%, ALTO: +6. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ALTO and ADM and BG and REX and INGR?
These companies operate in different sectors (ALTO (Basic Materials) and ADM (Consumer Defensive) and BG (Consumer Defensive) and REX (Basic Materials) and INGR (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ALTO is a small-cap quality compounder stock; ADM is a mid-cap quality compounder stock; BG is a mid-cap high-growth stock; REX is a small-cap quality compounder stock; INGR is a small-cap deep-value stock. ADM, BG, INGR pay a dividend while ALTO, REX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Consumer Defensive
- Market Cap > $100B
- Revenue Growth > 43%
- Dividend Yield > 0.8%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.